West Pharmaceutical Services, Inc., a global leader in solutions for injectable drug administration, has declared its regular quarterly dividend of $0.22 per share. The Board of Directors’ decision on July 21, 2026 underscores the company’s ongoing commitment to shareholders.

Baird Financial Group Inc. recently reduced its stake in Kenvue Inc. by 18.1%, selling nearly 156,000 shares in the first quarter. Despite this sale, Baird retains over 700,000 shares, valued at $16.93 million.